• Je něco špatně v tomto záznamu ?

Polymorphisms in some proinflammatory genes (TNFα and β, IL-1β, IL-6, ADAM17) in severe chronic venous disease

V. Slonková, A. Vašků, V. Vašků

. 2023 ; 37 (3) : 590-597. [pub] 20221203

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23004037

BACKGROUND: Chronic venous disease (CVD) is a common disorder of lower extremities. OBJECTIVES: The study was scheduled to investigate the relationship between polymorphisms in major proinflammatory genes TNF α (-238 A/G; -308 A/G), TNF β (NcoI), IL-1β (+3953 T/C); IL-6 (-174 G/C; -596 G/C) and ADAM17 (3'TACE) and CVD risk. Genotype-phenotype study was calculated to test possible association between examined genotypes and phenotypes of CVD. METHODS: Finally, 150 CVD patients and 227 control subjects were enrolled to the study. Genotypes in proinflammatory gene polymorphisms were identified from isolated DNA by PCR method and restriction analysis. RESULTS: Significant differences in genotype distribution/allelic frequencies in TNF β gene, IL-1 β gene and in ADAM17 gene polymorphisms were found between CVD women and control ones. In the genotype-phenotype study, identified genotypes were associated with arterial hypertension (ADAM17, IL-6-men), ischaemic heart disease (TNF α and β genes), diabetes mellitus (ADAM17-women, TNF β-men), age of CVD onset (TNF α and IL-6), ulceration (ADAM17), duration of ulceration (ADAM17), ulceration recurrence (ADAM17-women), home care necessity (TNF α), varices surgery (TNF α), erysipelas development (ADAM17-men) and tumour development (TNF α). CONCLUSION: Studying of these polymorphisms associations can help us better identify patients at higher risk of developing severe CVD.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004037
003      
CZ-PrNML
005      
20230425141042.0
007      
ta
008      
230418s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/jdv.18770 $2 doi
035    __
$a (PubMed)36420762
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Slonková, Veronika $u First Department of Dermatovenereology, St. Ann's Faculty Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic
245    10
$a Polymorphisms in some proinflammatory genes (TNFα and β, IL-1β, IL-6, ADAM17) in severe chronic venous disease / $c V. Slonková, A. Vašků, V. Vašků
520    9_
$a BACKGROUND: Chronic venous disease (CVD) is a common disorder of lower extremities. OBJECTIVES: The study was scheduled to investigate the relationship between polymorphisms in major proinflammatory genes TNF α (-238 A/G; -308 A/G), TNF β (NcoI), IL-1β (+3953 T/C); IL-6 (-174 G/C; -596 G/C) and ADAM17 (3'TACE) and CVD risk. Genotype-phenotype study was calculated to test possible association between examined genotypes and phenotypes of CVD. METHODS: Finally, 150 CVD patients and 227 control subjects were enrolled to the study. Genotypes in proinflammatory gene polymorphisms were identified from isolated DNA by PCR method and restriction analysis. RESULTS: Significant differences in genotype distribution/allelic frequencies in TNF β gene, IL-1 β gene and in ADAM17 gene polymorphisms were found between CVD women and control ones. In the genotype-phenotype study, identified genotypes were associated with arterial hypertension (ADAM17, IL-6-men), ischaemic heart disease (TNF α and β genes), diabetes mellitus (ADAM17-women, TNF β-men), age of CVD onset (TNF α and IL-6), ulceration (ADAM17), duration of ulceration (ADAM17), ulceration recurrence (ADAM17-women), home care necessity (TNF α), varices surgery (TNF α), erysipelas development (ADAM17-men) and tumour development (TNF α). CONCLUSION: Studying of these polymorphisms associations can help us better identify patients at higher risk of developing severe CVD.
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    12
$a TNF-alfa $x genetika $7 D014409
650    _2
$a interleukin-1beta $x genetika $7 D053583
650    _2
$a interleukin-6 $x genetika $7 D015850
650    _2
$a lymfotoxin-alfa $x genetika $7 D008233
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a genotyp $7 D005838
650    _2
$a chronická nemoc $7 D002908
650    _2
$a frekvence genu $7 D005787
650    12
$a kardiovaskulární nemoci $x genetika $7 D002318
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a protein ADAM17 $x genetika $7 D000072198
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vašků, Anna $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000299565823
700    1_
$a Vašků, Vladimír $u First Department of Dermatovenereology, St. Ann's Faculty Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic
773    0_
$w MED00002983 $t Journal of the European Academy of Dermatology and Venereology : JEADV $x 1468-3083 $g Roč. 37, č. 3 (2023), s. 590-597
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36420762 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425141038 $b ABA008
999    __
$a ok $b bmc $g 1924599 $s 1190246
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 37 $c 3 $d 590-597 $e 20221203 $i 1468-3083 $m Journal of the European Academy of Dermatology and Venereology $n J Eur Acad Dermatol Venerol $x MED00002983
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...